Financing, Medical device

Midatech gains £32 million in AIM float

Posted on 12 December 2014

Tags: ,

Midatech announced the Admission to trading on the AIM Market of the London Stock Exchange of its entire issued share capital, and the commencement of dealings, at 8.00 a.m. GMT today under the ticker code “MTPH” (ISIN number GB00BRTL9B63).

In conjunction with Admission, Midatech has raised £32 million (before expenses) by way of a placing of 11,985,019 new ordinary shares at 267 pence per share (the “Placing Price”).

Upon Admission, the Company will have 27,794,260 ordinary shares in issue, giving Midatech a market capitalisation of £74.2 million at the Placing Price.

In addition to the £32 million, an existing investor has subscribed £1.9 million, which was a debt due to repaid at the point of the Initial Public Offering.

For further deal information visit Current Agreements (subscription required)

Related

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

Report: Top 50 Big Biotech Partnering and M&A Deal Trends

Browse: Complete Current Partnering report catalog

Print Friendly, PDF & Email

Leave a Reply